Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5219]

PARP1 selective inhibitor yields potent and durable antitumour activity in patient-derived preclinical models

PARP1 selective inhibitor yields potent and durable antitumour activity in patient-derived preclinical models

Researchers identify key markers in pancreatic cancer progression using a new analysis pipeline

Researchers identify key markers in pancreatic cancer progression using a new analysis pipeline

Researchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells

Researchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells

New way to potentially slow cancer growth

New way to potentially slow cancer growth

Targeted cancer cell therapy may slow endometrial cancer

Targeted cancer cell therapy may slow endometrial cancer

Ovarian cancer discovery: targetable variant RAD51D found in Chinese patients

Ovarian cancer discovery: targetable variant RAD51D found in Chinese patients

Novel DNA-targeting therapeutic screening technique developed

Novel DNA-targeting therapeutic screening technique developed

Researchers shed light on overcoming cancer drug resistance unlocking potential to expand use of PARP inhibitors across cancer types

Researchers shed light on overcoming cancer drug resistance unlocking potential to expand use of PARP inhibitors...

Demystifying APE1: New findings on direct activation of ATM signalling by DNA single-strand breaks

Demystifying APE1: New findings on direct activation of ATM signalling by DNA single-strand breaks

The battle against glioblastoma: classifying molecular profiles for precision medicine

The battle against glioblastoma: classifying molecular profiles for precision medicine

More from ecancer